{"groups":[{"description":"See Detailed Description\n\nCyclosporine: Given IV or PO\n\nDasatinib: Given PO\n\nFludarabine Phosphate: Given IV\n\nImatinib Mesylate: Given PO\n\nMycophenolate Mofetil: Given PO\n\nNilotinib: Given PO\n\nNonmyeloablative Allogeneic Hematopoietic Stem Cell Transplantation: Undergo nonmyeloablative allogeneic PBSC transplantation\n\nPeripheral Blood Stem Cell Transplantation: Undergo allogeneic PBSC transplantation\n\nTherapeutic Allogeneic Lymphocytes: Given IV\n\nTotal-Body Irradiation: Undergo TBI","id":"FG000","title":"Treatment (Allogeneic Nonmyeloablative HSCT)"}],"periods":[{"milestones":[{"achievements":[{"groupId":"FG000","numSubjects":"28"}],"type":"STARTED"},{"achievements":[{"groupId":"FG000","numSubjects":"28"}],"type":"COMPLETED"},{"achievements":[{"groupId":"FG000","numSubjects":"0"}],"type":"NOT COMPLETED"}],"title":"Overall Study"}]}